start portlet menu bar

Visualitzador de contingut web

Display portlet menu
end portlet menu bar

Efficacy of the booster dose of SUISENG®: a novel friendly adjuvanted vaccine against neonatal colibacilosis and clostridiosis

Inici Coneixement Efficacy of the booster dose of SUISENG®: a novel friendly adjuvanted vaccine against neonatal colibacilosis and clostridiosis

Efficacy of the booster dose of SUISENG®: a novel friendly adjuvanted vaccine against neonatal colibacilosis and clostridiosis

This work shows the results of one study where the safety and the efficacy of SUISENG® (a vaccine against the Neonatal Piglet Colibacillosis, C. perfringens and C. novyi enterotoxicosis) were assessed. Applying the basic vaccination and the Revaccination to pregnant sows, the efficacy was evaluated by means the serological response, the transfer of maternal immunity and the clinical signs in challenged piglets with two pathogenic strains of E. coli.

Sobre aquest article

Autors

Liaño, N.; Gibert, X.; Roca, M.; Sitjá, M.

Resum

The results of this study demonstrated the efficacy of SUISENG® after a booster dose against the experimental infection with enterotoxigenic E. coli. The vaccination reduced significantly the clinical signs and the mortality of the piglets suffering from colibacillosis.

Serveis relacionats

Productes relacionats

Compartir